$MOH
MOLINA HEALTHCARE, INC. Stock $moh

$moh Overview Financials Valuation SEC Filings Company Website

2016 Q1 Form 10-Q Financial Statement

#000117992916000293 Filed on May 03, 2016

Income Statement

Concept	2016 Q1	2015 Q1
Revenue	$4.343B	$3.171B
YoY Change	36.96%	53.24%
Cost Of Revenue	$3.715B	$2.672B
YoY Change	39.05%	51.6%
Gross Profit	$434.0M	$351.0M
YoY Change	23.65%	14.37%
Gross Profit Margin	9.99%	11.07%
Selling, General & Admin	$507.0M	$392.2M
YoY Change	29.27%	49.69%
% of Gross Profit	116.82%	111.74%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$44.00M	$33.00M
YoY Change	33.33%	0.02%
% of Gross Profit	10.14%	9.4%
Operating Expenses	$539.0M	$417.2M
YoY Change	29.19%	47.58%
Operating Profit	$89.00M	$82.00M
YoY Change	8.54%	241.67%
Interest Expense	$25.00M	$15.00M
YoY Change	66.67%	8.52%
% of Operating Profit	28.09%	18.29%
Other Income/Expense, Net	-$25.00M	-$15.00M
YoY Change	66.67%	8.87%
Pretax Income	$64.00M	$67.00M
YoY Change	-4.48%	538.76%
Income Tax	$40.00M	$39.00M
% Of Pretax Income	62.5%	58.21%
Net Earnings	$24.00M	$28.00M
YoY Change	-14.29%	600.0%
Net Earnings / Revenue	0.55%	0.88%
Basic Earnings Per Share	$0.44	$0.58
Diluted Earnings Per Share	$0.43	$0.56
COMMON SHARES
Basic Shares Outstanding	55.00M shares	49.00M shares
Diluted Shares Outstanding	57.00M shares	50.00M shares

Balance Sheet

Concept	2016 Q1	2015 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$4.226B	$3.074B
YoY Change	37.48%	72.73%
Cash & Equivalents	$2.156B	$1.870B
Short-Term Investments	$2.070B	$1.204B
Other Short-Term Assets	$637.0M	$193.5M
YoY Change	229.2%	71.36%
Inventory
Prepaid Expenses
Receivables	$863.0M	$491.4M
Other Receivables	$38.00M	$0.00
Total Short-Term Assets	$5.764B	$4.276B
YoY Change	34.81%	87.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$419.0M	$344.7M
YoY Change	21.55%	11.07%
Goodwill	$619.0M	$272.0M
YoY Change	127.54%	17.9%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$37.00M	$34.06M
YoY Change	8.62%	-14.26%
Total Long-Term Assets	$1.419B	$894.2M
YoY Change	58.69%	-11.66%
TOTAL ASSETS
Total Short-Term Assets	$5.764B	$4.276B
Total Long-Term Assets	$1.419B	$894.2M
Total Assets	$7.183B	$5.170B
YoY Change	38.94%	56.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$601.0M	$427.6M
YoY Change	40.55%	5.22%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$455.0M	$440.6M
YoY Change	3.26%	139.85%
Total Short-Term Liabilities	$4.377B	$3.593B
YoY Change	21.81%	130.93%
LONG-TERM LIABILITIES
Long-Term Debt	$1.163B	$472.0M
YoY Change	146.4%	-23.33%
Other Long-Term Liabilities	$38.00M	$33.35M
YoY Change	13.95%	20.24%
Total Long-Term Liabilities	$38.00M	$33.35M
YoY Change	13.95%	20.24%
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.377B	$3.593B
Total Long-Term Liabilities	$38.00M	$33.35M
Total Liabilities	$5.593B	$4.128B
YoY Change	35.5%	72.3%
SHAREHOLDERS EQUITY
Retained Earnings	$782.0M	$643.5M
YoY Change	21.52%	15.4%
Common Stock	$806.0M	$398.1M
YoY Change	102.44%	16.95%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.590B	$1.042B
YoY Change
Total Liabilities & Shareholders Equity	$7.183B	$5.170B
YoY Change	38.94%	56.97%

Cashflow Statement

Concept	2016 Q1	2015 Q1
OPERATING ACTIVITIES
Net Income	$24.00M	$28.00M
YoY Change	-14.29%	600.0%
Depreciation, Depletion And Amortization	$44.00M	$33.00M
YoY Change	33.33%	0.02%
Cash From Operating Activities	$139.0M	$554.0M
YoY Change	-74.91%	162.69%
INVESTING ACTIVITIES
Capital Expenditures	$46.00M	-$25.00M
YoY Change	-284.0%	40.45%
Acquisitions	$2.000M	$8.000M
YoY Change	-75.0%
Other Investing Activities	-$1.000M	$7.000M
YoY Change	-114.29%	1179.71%
Cash From Investing Activities	-$314.0M	-$228.0M
YoY Change	37.72%	729.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$2.000M	$5.000M
YoY Change	-60.0%	-113.92%
NET CHANGE
Cash From Operating Activities	$139.0M	$554.0M
Cash From Investing Activities	-$314.0M	-$228.0M
Cash From Financing Activities	$2.000M	$5.000M
Net Change In Cash	-$173.0M	$331.0M
YoY Change	-152.27%	124.45%
FREE CASH FLOW
Cash From Operating Activities	$139.0M	$554.0M
Capital Expenditures	$46.00M	-$25.00M
Free Cash Flow	$93.00M	$579.0M
YoY Change	-83.94%	153.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2016Q1	dei	Amendment Flag AmendmentFlag	false
CY2016Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2016Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2016
CY2016Q1	dei	Document Period End Date DocumentPeriodEndDate	2016-03-31
CY2016Q1	dei	Document Type DocumentType	10-Q
CY2016Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001179929
CY2016Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	56584000	shares
CY2016Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2016Q1	dei	Entity Registrant Name EntityRegistrantName	MOLINA HEALTHCARE INC
CY2016Q1	dei	Trading Symbol TradingSymbol	moh
CY2015Q4	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable	-3000000	USD
CY2016Q1	moh	Affordable Care Act Premium Stabilization Program Minimum Medical Loss Ratio Receivable Payable AffordableCareActPremiumStabilizationProgramMinimumMedicalLossRatioReceivablePayable	-11000000	USD
CY2015Q4	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable	36000000	USD
CY2016Q1	moh	Affordable Care Act Premium Stabilization Program Reinsurance Receivable Payable AffordableCareActPremiumStabilizationProgramReinsuranceReceivablePayable	47000000	USD
CY2015Q4	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable	-214000000	USD
CY2016Q1	moh	Affordable Care Act Premium Stabilization Program Risk Adjustment Receivable Payable AffordableCareActPremiumStabilizationProgramRiskAdjustmentReceivablePayable	-301000000	USD
CY2015Q4	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable	-10000000	USD
CY2016Q1	moh	Affordable Care Act Premium Stabilization Program Risk Corridor Receivable Payable AffordableCareActPremiumStabilizationProgramRiskCorridorReceivablePayable	-15000000	USD
CY2016Q1	moh	Affordable Care Act Risk Adjustment Increase In Estimated Liability AffordableCareActRiskAdjustmentIncreaseInEstimatedLiability	20000000	USD
CY2015Q1	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	7000000	USD
CY2016Q1	moh	Amortizationof Debt Discount Premiumand Sale Leaseback Financing Obligation AmortizationofDebtDiscountPremiumandSaleLeasebackFinancingObligation	8000000	USD
CY2015Q4	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	-4000000	USD
CY2016Q1	moh	Anticipated Medicare Risk Adjustment Premiums AnticipatedMedicareRiskAdjustmentPremiums	13000000	USD
CY2015Q1	moh	Business Combination Prepaid Consideration Transferred BusinessCombinationPrepaidConsiderationTransferred	0	USD
CY2016Q1	moh	Business Combination Prepaid Consideration Transferred BusinessCombinationPrepaidConsiderationTransferred	-102000000	USD
CY2015Q4	moh	Capitation Claims Payable CapitationClaimsPayable	140000000	USD
CY2016Q1	moh	Capitation Claims Payable CapitationClaimsPayable	138000000	USD
CY2016Q1	moh	Class Of Warrant Or Right Trading Days Measurement Period ClassOfWarrantOrRightTradingDaysMeasurementPeriod	P160D
CY2016Q1	moh	Classof Warrantor Right Stated Percentage ClassofWarrantorRightStatedPercentage	0.01125
CY2015Q1	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	41000000	USD
CY2016Q1	moh	Health Care Organization Insurer Fee Expense HealthCareOrganizationInsurerFeeExpense	58000000	USD
CY2015Q1	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	48000000	USD
CY2016Q1	moh	Health Care Organization Insurer Fee Revenue HealthCareOrganizationInsurerFeeRevenue	90000000	USD
CY2015Q1	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	95000000	USD
CY2016Q1	moh	Health Care Organization Premium Tax Revenue HealthCareOrganizationPremiumTaxRevenue	109000000	USD
CY2015Q1	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	95000000	USD
CY2016Q1	moh	Increase Decreasein Medical Premium Liability Dueto Agency IncreaseDecreaseinMedicalPremiumLiabilityDuetoAgency	181000000	USD
CY2015Q4	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	198000000	USD
CY2016Q1	moh	Lease Financing Obligations Noncurrent LeaseFinancingObligationsNoncurrent	198000000	USD
CY2015Q4	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	167000000	USD
CY2016Q1	moh	Medical Claimsand Benefits Payable MedicalClaimsandBenefitsPayable	191000000	USD
CY2015	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	48000000	USD
CY2016Q1	moh	Medical Claimsand Benefits Payable Adjustments Changein Provider MedicalClaimsandBenefitsPayableAdjustmentsChangeinProvider	24000000	USD
CY2015Q4	moh	Medical Premium Liability Dueto Agency MedicalPremiumLiabilityDuetoAgency	729000000	USD
CY2016Q1	moh	Medical Premium Liability Dueto Agency MedicalPremiumLiabilityDuetoAgency	910000000	USD
CY2016Q1	moh	Numberof Members Added NumberofMembersAdded	425000	member
CY2015Q4	moh	Other Claims Payable OtherClaimsPayable	266000000	USD
CY2016Q1	moh	Other Claims Payable OtherClaimsPayable	299000000	USD
CY2015Q4	moh	Pharmacy Claims Payable PharmacyClaimsPayable	88000000	USD
CY2016Q1	moh	Pharmacy Claims Payable PharmacyClaimsPayable	111000000	USD
CY2015	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.118
CY2016Q1	moh	Policy Holder Benefits Prior Percentage PolicyHolderBenefitsPriorPercentage	0.100
CY2015	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.012
CY2016Q1	moh	Policy Holder Medical Care Cost Prior Year Percentage PolicyHolderMedicalCareCostPriorYearPercentage	0.013
CY2015	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.011
CY2016Q1	moh	Policy Holder Premium Revenue Prior Year Percentage PolicyHolderPremiumRevenuePriorYearPercentage	0.012
CY2015Q1	moh	Premium Tax Expenses PremiumTaxExpenses	95000000	USD
CY2016Q1	moh	Premium Tax Expenses PremiumTaxExpenses	109000000	USD
CY2015Q1	moh	Quality Incentive Premium Revenue As A Percentage Of Total Revenue QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue	0.003
CY2016Q1	moh	Quality Incentive Premium Revenue As A Percentage Of Total Revenue QualityIncentivePremiumRevenueAsAPercentageOfTotalRevenue	0.006
CY2016Q1	moh	Stock Issued During Period Valueand Income Tax Benefit Relatedto Sharebased Compensation StockIssuedDuringPeriodValueandIncomeTaxBenefitRelatedtoSharebasedCompensation	3000000	USD
CY2016Q1	moh	Unrecognized Compensation Forfeited Rate UnrecognizedCompensationForfeitedRate	0.038
CY2015Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	362000000	USD
CY2016Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	601000000	USD
CY2015Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-4000000	USD
CY2016Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2000000	USD
CY2016Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P5Y11M
CY2015Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	803000000	USD
CY2016Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	806000000	USD
CY2015Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6000000	USD
CY2016Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7000000	USD
CY2015Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7000000	USD
CY2016Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	7000000	USD
CY2015Q4	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1229000000	USD
CY2016Q1	us-gaap	Amount Of Restricted Net Assets For Consolidated And Unconsolidated Subsidiaries AmountOfRestrictedNetAssetsForConsolidatedAndUnconsolidatedSubsidiaries	1221000000	USD
CY2015Q4	us-gaap	Assets Assets	6576000000	USD
CY2016Q1	us-gaap	Assets Assets	7183000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	1000000	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	5306000000	USD
CY2016Q1	us-gaap	Assets Current AssetsCurrent	5764000000	USD
CY2015Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	1808000000	USD
CY2016Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	2068000000	USD
CY2015Q4	us-gaap	Available For Sale Securities AvailableForSaleSecurities	1801000000	USD
CY2016Q1	us-gaap	Available For Sale Securities AvailableForSaleSecurities	2070000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	4000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	7000000	USD
CY2016Q1	us-gaap	Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	2000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	6000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Less Than Twelve Months Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue	1135000000	USD
CY2015Q4	us-gaap	Available For Sale Securities Continuous Unrealized Loss Position Twelve Months Or Longer Fair Value AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue	119000000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	21000000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	21000000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	938000000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	940000000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	1109000000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	1109000000	USD
CY2016Q1	us-gaap	Available For Sale Securities Debt Maturities Without Single Maturity Date Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithoutSingleMaturityDateFairValue	2070000000	USD
CY2015Q4	us-gaap	Available For Sale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Less Than One Year AvailableForSaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsLessThanOneYear	846	Security
CY2015Q4	us-gaap	Availableforsale Securities In Unrealized Loss Positions Qualitative Disclosure Number Of Positions Greater Than Or Equal To One Year AvailableforsaleSecuritiesInUnrealizedLossPositionsQualitativeDisclosureNumberOfPositionsGreaterThanOrEqualToOneYear	87	Security
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1539000000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1870000000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2329000000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2156000000	USD
CY2015Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	331000000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-173000000	USD
CY2013Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	53.8475
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2016Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	56000000	shares
CY2016Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	57000000	shares
CY2015Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
CY2016Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	USD
CY2015Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	29000000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	30000000	USD
CY2015Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	962000000	USD
CY2016Q1	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	965000000	USD
CY2015Q1	us-gaap	Costs And Expenses CostsAndExpenses	3089000000	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	4254000000	USD
CY2015Q4	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	81000000	USD
CY2016Q1	us-gaap	Costs In Excess Of Billings On Uncompleted Contracts Or Programs Expected To Be Collected After One Year CostsInExcessOfBillingsOnUncompletedContractsOrProgramsExpectedToBeCollectedAfterOneYear	79000000	USD
CY2013	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	13490236	shares
CY2015Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1553000000	USD
CY2016Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1553000000	USD
CY2015Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	120000000	USD
CY2016Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	111000000	USD
CY2015Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	22000000	USD
CY2016Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	22000000	USD
CY2015Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	223000000	USD
CY2016Q1	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	94000000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	18000000	USD
CY2016Q1	us-gaap	Deferred Tax Assets Liabilities Net Noncurrent DeferredTaxAssetsLiabilitiesNetNoncurrent	0	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	0	USD
CY2016Q1	us-gaap	Deferred Tax Liabilities Noncurrent DeferredTaxLiabilitiesNoncurrent	15000000	USD
CY2015Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	25000000	USD
CY2016Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	32000000	USD
CY2015Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	33000000	USD
CY2016Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	44000000	USD
CY2015Q4	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	374000000	USD
CY2016Q1	us-gaap	Derivative Assets Current DerivativeAssetsCurrent	377000000	USD
CY2015Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2016Q1	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	0	USD
CY2015Q4	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	374000000	USD
CY2016Q1	us-gaap	Derivative Liabilities Current DerivativeLiabilitiesCurrent	377000000	USD
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.58
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.44
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.56
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.43
CY2016Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	53000000	USD
CY2016Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y1M
CY2015Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	0	USD
CY2016Q1	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	134000000	USD
CY2015Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	122000000	USD
CY2016Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	149000000	USD
CY2016Q1	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	34000000	USD
CY2015Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	256000000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	340000000	USD
CY2015Q4	us-gaap	Goodwill Goodwill	519000000	USD
CY2016Q1	us-gaap	Goodwill Goodwill	619000000	USD
CY2016Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	98000000	USD
CY2015Q1	us-gaap	Gross Profit GrossProfit	351000000	USD
CY2016Q1	us-gaap	Gross Profit GrossProfit	420000000	USD
CY2015Q1	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	2000000	USD
CY2016Q1	us-gaap	Health Care Organization Other Revenue HealthCareOrganizationOtherRevenue	1000000	USD
CY2015Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	2971000000	USD
CY2016Q1	us-gaap	Health Care Organization Premium Revenue HealthCareOrganizationPremiumRevenue	3995000000	USD
CY2016Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	116000000	USD
CY2016Q1	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	5000000	USD
CY2016Q1	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	5000000	USD
CY2016Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	111000000	USD
CY2016Q1	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	111000000	USD
CY2016Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	116000000	USD
CY2015Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	67000000	USD
CY2016Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	64000000	USD
CY2015Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	39000000	USD
CY2016Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	40000000	USD
CY2015Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	13000000	USD
CY2016Q1	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	38000000	USD
CY2015Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	189000000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	205000000	USD
CY2015Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	2000000	USD
CY2016Q1	us-gaap	Increase Decrease In Accrued Income Taxes Payable IncreaseDecreaseInAccruedIncomeTaxesPayable	-24000000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-1000000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-30000000	USD
CY2015Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-26000000	USD
CY2016Q1	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-129000000	USD
CY2015Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	248000000	USD
CY2016Q1	us-gaap	Increase Decrease In Health Care Insurance Liabilities IncreaseDecreaseInHealthCareInsuranceLiabilities	255000000	USD
CY2015Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	137000000	USD
CY2016Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	202000000	USD
CY2015Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	-105000000	USD
CY2016Q1	us-gaap	Increase Decrease In Receivables IncreaseDecreaseInReceivables	266000000	USD
CY2015Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	5000000	USD
CY2016Q1	us-gaap	Increase Decrease Of Restricted Investments IncreaseDecreaseOfRestrictedInvestments	4000000	USD
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1000000	shares
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	1000000	shares
CY2015Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2016Q1	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	1000000	shares
CY2015Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	3000000	USD
CY2016Q1	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	8000000	USD
CY2015Q1	us-gaap	Interest Expense InterestExpense	15000000	USD
CY2016Q1	us-gaap	Interest Expense InterestExpense	25000000	USD
CY2015Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	10000000	USD
CY2016Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	19000000	USD
CY2015Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3000000	USD
CY2016Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	12000000	USD
CY2015Q4	us-gaap	Liabilities Liabilities	5019000000	USD
CY2016Q1	us-gaap	Liabilities Liabilities	5593000000	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	6576000000	USD
CY2016Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7183000000	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3822000000	USD
CY2016Q1	us-gaap	Liabilities Current LiabilitiesCurrent	4377000000	USD
CY2014Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1201000000	USD
CY2015Q4	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1685000000	USD
CY2016Q1	us-gaap	Liability For Claims And Claims Adjustment Expense LiabilityForClaimsAndClaimsAdjustmentExpense	1940000000	USD
CY2015	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	10448000000	USD
CY2016Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Current Year1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidCurrentYear1	2241000000	USD
CY2015	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	910000000	USD
CY2016Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Claims Paid Prior Years1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseClaimsPaidPriorYears1	1116000000	USD
CY2015Q4	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	1191000000	USD
CY2016Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred But Not Reported Ibnr Claims Amount LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredButNotReportedIBNRClaimsAmount	1392000000	USD
CY2015	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	11794000000	USD
CY2016Q1	us-gaap	Liability For Unpaid Claims And Claims Adjustment Expense Incurred Claims1 LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseIncurredClaims1	3588000000	USD
CY2015Q4	us-gaap	Long Term Debt LongTermDebt	1411000000	USD
CY2016Q1	us-gaap	Long Term Debt LongTermDebt	1420000000	USD
CY2015Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	449000000	USD
CY2016Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	455000000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	1002000000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	550000000	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	0	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	0	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	0	USD
CY2016Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	1000000	USD
CY2015Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1801000000	USD
CY2016Q1	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	2070000000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5000000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2000000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-228000000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-314000000	USD
CY2015Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	554000000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	139000000	USD
CY2015Q1	us-gaap	Net Income Loss NetIncomeLoss	28000000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	24000000	USD
CY2015Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-15000000	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-25000000	USD
CY2016Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	Segment
CY2015Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	82000000	USD
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	89000000	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	28000000	USD
CY2016Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	37000000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	6000000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	2000000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	9000000	USD
CY2015Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	1000000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	3000000	USD
CY2015Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	37000000	USD
CY2016Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	38000000	USD
CY2015Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	3000000	USD
CY2016Q1	us-gaap	Other Operating Activities Cash Flow Statement OtherOperatingActivitiesCashFlowStatement	6000000	USD
CY2015	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	11358000000	USD
CY2016Q1	us-gaap	Payments For Losses And Loss Adjustment Expense PaymentsForLossesAndLossAdjustmentExpense	3357000000	USD
CY2015Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	7000000	USD
CY2016Q1	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-1000000	USD
CY2015Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	8000000	USD
CY2016Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	2000000	USD
CY2015Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	25000000	USD
CY2016Q1	us-gaap	Payments To Acquire Machinery And Equipment PaymentsToAcquireMachineryAndEquipment	46000000	USD
CY2015Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	438000000	USD
CY2016Q1	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	611000000	USD
CY2015Q1	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	2636000000	USD
CY2016Q1	us-gaap	Policyholder Benefits And Claims Incurred Health Care PolicyholderBenefitsAndClaimsIncurredHealthCare	3588000000	USD
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2016Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2016Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2015Q4	us-gaap	Premiums Receivable Gross PremiumsReceivableGross	3000000	USD
CY2016Q1	us-gaap	Premiums Receivable Gross PremiumsReceivableGross	1000000	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	192000000	USD
CY2016Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	260000000	USD
CY2015Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1000000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	0	USD
CY2015Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	4000000	USD
CY2016Q1	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	2000000	USD
CY2015Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	255000000	USD
CY2016Q1	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	348000000	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	393000000	USD
CY2016Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	419000000	USD
CY2015Q4	us-gaap	Receivables Net Current ReceivablesNetCurrent	597000000	USD
CY2016Q1	us-gaap	Receivables Net Current ReceivablesNetCurrent	863000000	USD
CY2015Q4	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	109000000	USD
CY2016Q1	us-gaap	Restricted Investments Noncurrent RestrictedInvestmentsNoncurrent	116000000	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	758000000	USD
CY2016Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	782000000	USD
CY2015Q1	us-gaap	Revenues Revenues	3171000000	USD
CY2016Q1	us-gaap	Revenues Revenues	4343000000	USD
CY2015Q1	us-gaap	Share Based Compensation ShareBasedCompensation	6000000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	7000000	USD
CY2016Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Balance StatutoryAccountingPracticesStatutoryCapitalAndSurplusBalance	1349000000	USD
CY2016Q1	us-gaap	Statutory Accounting Practices Statutory Capital And Surplus Required StatutoryAccountingPracticesStatutoryCapitalAndSurplusRequired	854000000	USD
CY2015Q1	us-gaap	Stock Issued1 StockIssued1	9000000	USD
CY2016Q1	us-gaap	Stock Issued1 StockIssued1	7000000	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	1557000000	USD
CY2016Q1	us-gaap	Stockholders Equity StockholdersEquity	1590000000	USD
CY2016Q1	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	33000000	USD
CY2015Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	-8000000	USD
CY2016Q1	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	30000000	USD
CY2015	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	11935000000	USD
CY2016Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Current Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersCurrentYearClaimsAndClaimsAdjustmentExpense	3755000000	USD
CY2015	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-141000000	USD
CY2016Q1	us-gaap	Supplemental Information For Property Casualty Insurance Underwriters Prior Year Claims And Claims Adjustment Expense SupplementalInformationForPropertyCasualtyInsuranceUnderwritersPriorYearClaimsAndClaimsAdjustmentExpense	-167000000	USD
CY2015Q1	us-gaap	Technology Services Costs TechnologyServicesCosts	36000000	USD
CY2016Q1	us-gaap	Technology Services Costs TechnologyServicesCosts	127000000	USD
CY2015Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	52000000	USD
CY2016Q1	us-gaap	Technology Services Revenue TechnologyServicesRevenue	140000000	USD
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50000000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	57000000	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	49000000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	55000000	shares
CY2016Q1	us-gaap	Schedule Of Liability For Unpaid Claims And Claims Adjustment Expense ScheduleOfLiabilityForUnpaidClaimsAndClaimsAdjustmentExpense	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:8px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The following table provides the details of our medical claims and benefits payable (including amounts payable for the provision of long-term services and supports, or LTSS) as of the dates indicated.</font></div><div style="line-height:120%;padding-top:8px;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="8" rowspan="1"></td></tr><tr><td style="width:73%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td><td style="width:11%;" rowspan="1" colspan="1"></td><td style="width:1%;" rowspan="1" colspan="1"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">March 31, <br clear="none"/>2016</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="3" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">December 31,<br clear="none"/>2015</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;"> </font></div></td><td colspan="7" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(In millions)</font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Fee-for-service claims incurred but not paid (IBNP)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,392</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,191</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pharmacy payable</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">111</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">88</font></div></td><td style="vertical-align:bottom;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Capitation payable</font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">138</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">140</font></div></td><td style="vertical-align:bottom;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Other</font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">299</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td colspan="2" style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;" rowspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">266</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr><tr><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,940</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td><td style="vertical-align:bottom;background-color:#cceeff;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;" rowspan="1" colspan="1"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">$</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;padding-top:2px;padding-bottom:2px;" rowspan="1" colspan="1"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">1,685</font></div></td><td style="vertical-align:bottom;border-bottom:3px double #000000;background-color:#cceeff;" rowspan="1" colspan="1"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br clear="none"/></font></div></td></tr></table></div></div></div>

Files In Submission

Name	View Source	Status
0001179929-16-000293-index-headers.html	Edgar Link	pending
0001179929-16-000293-index.html	Edgar Link	pending
0001179929-16-000293.txt	Edgar Link	pending
0001179929-16-000293-xbrl.zip	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
moh-03312016x10q.htm	Edgar Link	pending
moh-03312016x10qex311.htm	Edgar Link	pending
moh-03312016x10qex312.htm	Edgar Link	pending
moh-03312016x10qex321.htm	Edgar Link	pending
moh-03312016x10qex322.htm	Edgar Link	pending
moh-20160331.xml	Edgar Link	completed
moh-20160331.xsd	Edgar Link	pending
moh-20160331_cal.xml	Edgar Link	unprocessable
moh-20160331_def.xml	Edgar Link	unprocessable
moh-20160331_lab.xml	Edgar Link	unprocessable
moh-20160331_pre.xml	Edgar Link	unprocessable
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MOH
MOLINA HEALTHCARE, INC. Stock $moh

2016 Q1 Form 10-Q Financial Statement

#000117992916000293 Filed on May 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH MOLINA HEALTHCARE, INC. Stock $moh

2016 Q1 Form 10-Q Financial Statement

#000117992916000293 Filed on May 03, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MOH
MOLINA HEALTHCARE, INC. Stock $moh